Skip to Main Content

Bristol-Myers Squibb Co.

BMY Real Time Price USD
N/A
N/A
N/A
...
Overview
Financials
Insiders
Institutions
Government

$BMY stock is featured in our Tom Carper, Top Lobbying Spenders, and Lobbying Spending Growth strategies.

See All Strategies
Income
Balance Sheet
Cash Flow
BMY Income Statement
BMY Balance Sheet
BMY Cash Flow

Recent trades of BMY by members of U.S. Congress

Politician Type Traded
Tommy Tuberville Senate / R Sale (Full) $1,001 - $15,000 Apr. 03, 2024
Tommy Tuberville Senate / R Purchase $1,001 - $15,000 Apr. 03, 2024
John James House / R Sale $1,001 - $15,000 Jan. 18, 2024
Rick Larsen House / D Sale $1,001 - $15,000 Jan. 09, 2024
Tommy Tuberville Senate / R Sale (Partial) $1,001 - $15,000 Jan. 03, 2024
Tommy Tuberville Senate / R Sale (Full) $1,001 - $15,000 Nov. 16, 2023
John James House / R Purchase $1,001 - $15,000 Nov. 10, 2023
HON. GREG STANTON House / D Sale $1,001 - $15,000 Oct. 24, 2023
Tommy Tuberville Senate / R Purchase $1,001 - $15,000 Oct. 17, 2023
HON. GREG STANTON House / D Purchase $1,001 - $15,000 Sep. 26, 2023
Dan Sullivan Senate / R Sale (Full) $1,001 - $15,000 Aug. 22, 2023
Daniel S. Goldman House / D Sale $15,001 - $50,000 Jul. 12, 2023
Shelley Moore Capito Senate / R Sale (Full) $1,001 - $15,000 May. 10, 2023
Daniel S. Goldman House / D Purchase $50,001 - $100,000 Apr. 10, 2023
Daniel S. Goldman House / D Sale $1,001 - $15,000 Mar. 07, 2023
Daniel S. Goldman House / D Sale $100,001 - $250,000 Mar. 06, 2023
Dan Sullivan Senate / R Sale (Partial) $1,001 - $15,000 Jan. 10, 2023
Nicholas V. Taylor House / R Sale $100,001 - $250,000 Nov. 28, 2022
Kathy E. Manning House / D Purchase $1,001 - $15,000 Jul. 15, 2022
Shelley Moore Capito Senate / R Sale (Partial) $1,001 - $15,000 Jun. 17, 2022
John H. Rutherford House / R Sale $1,001 - $15,000 Mar. 16, 2022
Thomas R. Carper Senate / D Purchase $1,001 - $15,000 Jan. 18, 2022
Thomas R. Carper Senate / D Purchase $1,001 - $15,000 Nov. 29, 2021
Carol D. Miller House / R Sale $15,001 - $50,000 Nov. 10, 2021
Kim Schrier House / D Sale $1,001 - $15,000 Oct. 28, 2021
John A. Yarmuth House / D Purchase $1,001 - $15,000 Sep. 23, 2021
John A. Yarmuth House / D Purchase $1,001 - $15,000 Sep. 22, 2021
Thomas R. Suozzi House / D Sale $1,001 - $15,000 Jun. 07, 2021
Thomas R. Suozzi House / D Sale $1,001 - $15,000 Jun. 04, 2021
Thomas R. Carper Senate / D Purchase $1,001 - $15,000 Dec. 30, 2020
Rick Larsen House / D Purchase $1,001 - $15,000 Nov. 25, 2020
Katherine M. Clark House / D Sale $1,001 - $15,000 Oct. 22, 2020
Katherine M. Clark House / D Sale $1,001 - $15,000 Oct. 22, 2020
Thomas R. Suozzi House / D Sale $1,001 - $15,000 Jul. 30, 2020
Thomas R. Suozzi House / D Sale $1,001 - $15,000 Jul. 10, 2020
John H. Rutherford House / R Purchase $1,001 - $15,000 Jun. 21, 2020
David Perdue Senate / R Sale (Full) $1,001 - $15,000 Apr. 16, 2020
David Perdue Senate / R Sale (Partial) $15,001 - $50,000 Apr. 14, 2020
David Perdue Senate / R Sale (Full) $15,001 - $50,000 Apr. 14, 2020
Kelly Loeffler Senate / R Sale (Full) $100,001 - $250,000 Apr. 14, 2020
Kelly Loeffler Senate / R Sale (Full) $250,001 - $500,000 Apr. 14, 2020
Katherine M. Clark House / D Purchase $1,001 - $15,000 Apr. 03, 2020
Katherine M. Clark House / D Purchase $1,001 - $15,000 Apr. 03, 2020
Gilbert Ray Cisneros, Jr. House / D Sale $1,001 - $15,000 Mar. 18, 2020
Nicholas V. Taylor House / R Sale $100,001 - $250,000 Mar. 13, 2020
Mikie Sherrill House / D Sale $1,001 - $15,000 Feb. 20, 2020
Mikie Sherrill House / D Purchase $1,001 - $15,000 Jan. 21, 2020
Gilbert Ray Cisneros, Jr. House / D Purchase $1,001 - $15,000 Jan. 14, 2020
Thomas R. Suozzi House / D Purchase $50,001 - $100,000 Jan. 09, 2020
Thomas R. Suozzi House / D Sale $15,001 - $50,000 Jan. 09, 2020
BMY Stock Insider Trading Activity
Name
Type
Shares
Price
Shares Held
Date
Reported
BMY Stock Institutional Owners
Investor
Shares
Change in Shares
Market Value
Date
Reported
BMY Derivatives Institutional Owners
Investor
Type
Shares
Change in Shares
Market Value
Date
Reported

Recently reported changes by institutional investors

Quarterly net insider trading by BMY's directors and management

Government lobbying spending instances

  • $3,250,000 Oct 21, 2024 Issue: Trade (domestic/foreign) Pharmacy Copyright/Patent/Trademark Taxation/Internal Revenue Code Medicare/Medicaid Health Issues
  • $640,000 Jul 22, 2024 Issue: Pharmacy Copyright/Patent/Trademark Taxation/Internal Revenue Code Medicare/Medicaid Health Issues
  • $600,000 Apr 22, 2024 Issue: Manufacturing Pharmacy Copyright/Patent/Trademark Taxation/Internal Revenue Code Medicare/Medicaid Health Issues
  • $2,060,000 Jan 21, 2024 Issue: Budget/Appropriations Taxation/Internal Revenue Code Medicare/Medicaid Health Issues
  • $2,180,000 Oct 20, 2023 Issue: Copyright/Patent/Trademark Taxation/Internal Revenue Code Medicare/Medicaid Health Issues
  • $2,230,000 Jul 19, 2023 Issue: Copyright/Patent/Trademark Taxation/Internal Revenue Code Trade (domestic/foreign) Medicare/Medicaid Health Issues
  • $2,410,000 Apr 20, 2023 Issue: Copyright/Patent/Trademark Taxation/Internal Revenue Code Trade (domestic/foreign) Medicare/Medicaid Health Issues
  • $640,000 Jan 20, 2023 Issue: Budget/Appropriations Taxation/Internal Revenue Code Trade (domestic/foreign) Medicare/Medicaid Health Issues
  • $870,000 Oct 20, 2022 Issue: Taxation/Internal Revenue Code Trade (domestic/foreign) Medicare/Medicaid Health Issues
  • $1,590,000 Jul 20, 2022 Issue: Taxation/Internal Revenue Code Trade (domestic/foreign) Medicare/Medicaid Health Issues
  • $2,300,000 Apr 20, 2022 Issue: Taxation/Internal Revenue Code Trade (domestic/foreign) Medicare/Medicaid Health Issues Copyright/Patent/Trademark
  • $730,000 Feb 07, 2022 Issue: None
  • $710,000 Jan 20, 2022 Issue: None
  • $1,740,000 Oct 20, 2021 Issue: None
  • $2,230,000 Jul 20, 2021 Issue: None
  • $1,090,000 May 17, 2021 Issue: None
  • $730,000 Apr 20, 2021 Issue: None
  • $1,600,000 Oct 19, 2020 Issue: None
  • $2,160,000 Jul 20, 2020 Issue: None
  • $540,000 Apr 20, 2020 Issue: None
  • $690,000 Jan 17, 2020 Issue: None
  • $1,240,000 Oct 17, 2019 Issue: Medicare/Medicaid Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Trade (domestic/foreign)
  • $970,000 Jul 19, 2019 Issue: Medicare/Medicaid Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Trade (domestic/foreign)
  • $1,200,000 Apr 19, 2019 Issue: Medicare/Medicaid Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Trade (domestic/foreign)
  • $940,000 Jan 18, 2019 Issue: Budget/Appropriations Medicare/Medicaid Health Issues Copyright/Patent/Trademark Trade (domestic/foreign) Taxation/Internal Revenue Code
  • $960,000 Oct 19, 2018 Issue: Budget/Appropriations Medicare/Medicaid Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Trade (domestic/foreign)
  • $1,130,000 Jul 18, 2018 Issue: Budget/Appropriations Medicare/Medicaid Health Issues Copyright/Patent/Trademark Trade (domestic/foreign) Taxation/Internal Revenue Code
  • $800,000 Apr 18, 2018 Issue: Budget/Appropriations Medicare/Medicaid Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Trade (domestic/foreign)
  • $860,000 Jan 18, 2018 Issue: Budget/Appropriations Medicare/Medicaid Health Issues Trade (domestic/foreign) Copyright/Patent/Trademark
  • $900,000 Oct 18, 2017 Issue: Budget/Appropriations Medicare/Medicaid Health Issues Trade (domestic/foreign) Copyright/Patent/Trademark
  • $860,000 Jul 17, 2017 Issue: Medicare/Medicaid Health Issues Copyright/Patent/Trademark Trade (domestic/foreign) Budget/Appropriations
  • $990,000 Apr 19, 2017 Issue: Budget/Appropriations Medicare/Medicaid Health Issues Trade (domestic/foreign) Copyright/Patent/Trademark
  • $560,000 Jan 19, 2017 Issue: Budget/Appropriations Medicare/Medicaid Health Issues Copyright/Patent/Trademark Trade (domestic/foreign)
  • $670,000 Nov 29, 2016 Issue: Medicare/Medicaid Health Issues Copyright/Patent/Trademark Trade (domestic/foreign) Budget/Appropriations
  • $810,000 Oct 19, 2016 Issue: Budget/Appropriations Medicare/Medicaid Health Issues Copyright/Patent/Trademark Trade (domestic/foreign)
  • $690,000 Apr 19, 2016 Issue: Budget/Appropriations Medicare/Medicaid Health Issues Copyright/Patent/Trademark Trade (domestic/foreign)
  • $780,000 Jan 18, 2016 Issue: Budget/Appropriations Medicare/Medicaid Health Issues Copyright/Patent/Trademark Trade (domestic/foreign)
  • $850,000 Oct 19, 2015 Issue: Budget/Appropriations Medicare/Medicaid Health Issues Copyright/Patent/Trademark Trade (domestic/foreign)
  • $670,000 Jul 20, 2015 Issue: Budget/Appropriations Medicare/Medicaid Health Issues Copyright/Patent/Trademark Trade (domestic/foreign)
  • $610,000 Apr 17, 2015 Issue: Budget/Appropriations Medicare/Medicaid Health Issues Copyright/Patent/Trademark Trade (domestic/foreign)
  • $770,000 Jan 16, 2015 Issue: Medicare/Medicaid Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Trade (domestic/foreign)
  • $680,000 Oct 17, 2014 Issue: Medicare/Medicaid Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Trade (domestic/foreign)
  • $775,000 Jul 17, 2014 Issue: Medicare/Medicaid Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Trade (domestic/foreign)
  • $520,000 Apr 17, 2014 Issue: Medicare/Medicaid Health Issues Trade (domestic/foreign) Copyright/Patent/Trademark
  • $740,000 Jan 17, 2014 Issue: Budget/Appropriations Medicare/Medicaid Health Issues Copyright/Patent/Trademark Trade (domestic/foreign)
  • $542,000 Oct 18, 2013 Issue: Budget/Appropriations Medicare/Medicaid Health Issues Trade (domestic/foreign)
  • $724,000 Jul 16, 2013 Issue: Budget/Appropriations Medicare/Medicaid Health Issues Trade (domestic/foreign)
  • $830,000 Apr 18, 2013 Issue: Budget/Appropriations Medicare/Medicaid Health Issues
  • $1,280,000 Jan 22, 2013 Issue: Budget/Appropriations Medicare/Medicaid Health Issues Copyright/Patent/Trademark
  • $520,000 Oct 17, 2012 Issue: Budget/Appropriations Medicare/Medicaid Health Issues Copyright/Patent/Trademark
  • $820,000 Jul 18, 2012 Issue: Budget/Appropriations Medicare/Medicaid Health Issues Copyright/Patent/Trademark
  • $660,000 Jul 18, 2012 Issue: Budget/Appropriations Medicare/Medicaid Health Issues Copyright/Patent/Trademark
  • $870,000 Jan 18, 2012 Issue: Budget/Appropriations Medicare/Medicaid Health Issues Copyright/Patent/Trademark
  • $660,000 Oct 18, 2011 Issue: Budget/Appropriations Medicare/Medicaid Health Issues Copyright/Patent/Trademark
  • $560,000 Jul 20, 2011 Issue: Medicare/Medicaid Health Issues Copyright/Patent/Trademark
  • $1,040,000 Jul 19, 2011 Issue: Medicare/Medicaid Health Issues Copyright/Patent/Trademark
  • $509,000 Jul 19, 2011 Issue: Medicare/Medicaid Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code
  • $795,000 Oct 19, 2010 Issue: Medicare/Medicaid Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code
  • $980,000 Jul 19, 2010 Issue: Medicare/Medicaid Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code
  • $1,060,000 Apr 19, 2010 Issue: Medicare/Medicaid Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code
  • $860,000 Apr 19, 2010 Issue: Welfare Consumer Issues/Safety/Products Budget/Appropriations Medicare/Medicaid Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Trade (domestic/foreign)
  • $952,580 Oct 20, 2009 Issue: Medicare/Medicaid Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Trade (domestic/foreign) Budget/Appropriations Consumer Issues/Safety/Products Welfare
  • $809,000 Jul 16, 2009 Issue: Consumer Issues/Safety/Products Budget/Appropriations Medicare/Medicaid Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Welfare
  • $814,676 Apr 17, 2009 Issue: Welfare Consumer Issues/Safety/Products Budget/Appropriations Medicare/Medicaid Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code
  • $1,025,520 Jan 21, 2009 Issue: Law Enforcement/Crime/Criminal Justice Clean Air and Water (quality) Medical/Disease Research/Clinical Labs Consumer Issues/Safety/Products Medicare/Medicaid Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code
  • $840,000 Oct 16, 2008 Issue: Law Enforcement/Crime/Criminal Justice Medical/Disease Research/Clinical Labs Consumer Issues/Safety/Products Medicare/Medicaid Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Clean Air and Water (quality)
  • $830,000 Jul 21, 2008 Issue: Clean Air and Water (quality) Consumer Issues/Safety/Products Medicare/Medicaid Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Trade (domestic/foreign) Medical/Disease Research/Clinical Labs
  • $840,000 Apr 18, 2008 Issue: Clean Air and Water (quality) Consumer Issues/Safety/Products Medicare/Medicaid Health Issues Copyright/Patent/Trademark Agriculture Trade (domestic/foreign) Taxation/Internal Revenue Code
  • $2,660,000 Mar 12, 2008 Issue: Budget/Appropriations Medicare/Medicaid Health Issues Taxation/Internal Revenue Code Agriculture Trade (domestic/foreign) Copyright/Patent/Trademark
  • $2,840,000 Sep 17, 2007 Issue: Trade (domestic/foreign) Agriculture Taxation/Internal Revenue Code Health Issues Copyright/Patent/Trademark Medicare/Medicaid Budget/Appropriations
  • $2,980,000 Feb 12, 2007 Issue: Medical/Disease Research/Clinical Labs Budget/Appropriations Medicare/Medicaid Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Trade (domestic/foreign)
  • $2,760,000 Aug 10, 2006 Issue: Advertising Clean Air and Water (quality) Torts Medical/Disease Research/Clinical Labs Pharmacy Budget/Appropriations Medicare/Medicaid Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Trade (domestic/foreign) Economics/Economic Development Environment/Superfund Insurance Consumer Issues/Safety/Products Government Issues Energy/Nuclear Telecommunications Foreign Relations Food Industry (safety, labeling, etc.) Labor Issues/Antitrust/Workplace Law Enforcement/Crime/Criminal Justice
  • $2,580,000 Feb 14, 2006 Issue: Medical/Disease Research/Clinical Labs Budget/Appropriations Medicare/Medicaid Health Issues Taxation/Internal Revenue Code Copyright/Patent/Trademark Trade (domestic/foreign)
  • $2,460,000 Aug 11, 2005 Issue: Taxation/Internal Revenue Code Copyright/Patent/Trademark Health Issues Medicare/Medicaid Budget/Appropriations Medical/Disease Research/Clinical Labs Torts
  • $2,860,000 Feb 11, 2005 Issue: Trade (domestic/foreign) Taxation/Internal Revenue Code Copyright/Patent/Trademark Health Issues Foreign Relations Medicare/Medicaid Budget/Appropriations Insurance Government Issues Torts
  • $2,720,000 Aug 13, 2004 Issue: Health Issues Foreign Relations Clean Air and Water (quality) Advertising Trade (domestic/foreign) Taxation/Internal Revenue Code Copyright/Patent/Trademark Medicare/Medicaid Budget/Appropriations Insurance Consumer Issues/Safety/Products Government Issues Food Industry (safety, labeling, etc.) Torts
  • $2,740,000 Feb 12, 2004 Issue: Advertising Clean Air and Water (quality) Torts Food Industry (safety, labeling, etc.) Taxation/Internal Revenue Code Copyright/Patent/Trademark Economics/Economic Development Health Issues Foreign Relations Medicare/Medicaid Budget/Appropriations Insurance Consumer Issues/Safety/Products Government Issues Trade (domestic/foreign)
  • $2,580,000 Aug 07, 2003 Issue: Advertising Clean Air and Water (quality) Torts Food Industry (safety, labeling, etc.) Government Issues Consumer Issues/Safety/Products Insurance Budget/Appropriations Medicare/Medicaid Trade (domestic/foreign) Taxation/Internal Revenue Code Copyright/Patent/Trademark Economics/Economic Development Health Issues Foreign Relations
  • $2,420,000 Mar 14, 2003 Issue: None
  • $2,480,000 Aug 01, 2002 Issue: Advertising Law Enforcement/Crime/Criminal Justice Clean Air and Water (quality) Medical/Disease Research/Clinical Labs Pharmacy Labor Issues/Antitrust/Workplace Government Issues Copyright/Patent/Trademark Telecommunications Taxation/Internal Revenue Code Health Issues Foreign Relations Consumer Issues/Safety/Products Medicare/Medicaid Budget/Appropriations Environment/Superfund Insurance Economics/Economic Development Trade (domestic/foreign)
  • $2,400,000 Feb 14, 2002 Issue: Foreign Relations Health Issues Medicare/Medicaid Telecommunications Copyright/Patent/Trademark Economics/Economic Development Budget/Appropriations Environment/Superfund Insurance Consumer Issues/Safety/Products Government Issues Labor Issues/Antitrust/Workplace Pharmacy Medical/Disease Research/Clinical Labs Clean Air and Water (quality) Law Enforcement/Crime/Criminal Justice Advertising Trade (domestic/foreign) Taxation/Internal Revenue Code
  • $2,460,000 Aug 14, 2001 Issue: Advertising Law Enforcement/Crime/Criminal Justice Clean Air and Water (quality) Medical/Disease Research/Clinical Labs Pharmacy Labor Issues/Antitrust/Workplace Government Issues Consumer Issues/Safety/Products Insurance Foreign Relations Health Issues Economics/Economic Development Copyright/Patent/Trademark Taxation/Internal Revenue Code Trade (domestic/foreign) Medicare/Medicaid Telecommunications Budget/Appropriations Environment/Superfund
  • $2,220,000 Aug 01, 2001 Issue: Law Enforcement/Crime/Criminal Justice Environment/Superfund Budget/Appropriations Medicare/Medicaid Foreign Relations Health Issues Copyright/Patent/Trademark Trade (domestic/foreign) Taxation/Internal Revenue Code Consumer Issues/Safety/Products Government Issues Clean Air and Water (quality)
  • $2,440,000 Aug 10, 2000 Issue: Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Foreign Relations Medicare/Medicaid Trade (domestic/foreign) Budget/Appropriations Environment/Superfund Consumer Issues/Safety/Products Government Issues Energy/Nuclear Clean Air and Water (quality) Law Enforcement/Crime/Criminal Justice
  • $2,020,000 Feb 10, 2000 Issue: Law Enforcement/Crime/Criminal Justice Clean Air and Water (quality) Environment/Superfund Budget/Appropriations Medicare/Medicaid Foreign Relations Government Issues Trade (domestic/foreign) Taxation/Internal Revenue Code Copyright/Patent/Trademark Health Issues Consumer Issues/Safety/Products Energy/Nuclear
  • $1,600,000 Aug 10, 1999 Issue: Trade (domestic/foreign) Taxation/Internal Revenue Code Copyright/Patent/Trademark Health Issues Foreign Relations Medicare/Medicaid Budget/Appropriations Environment/Superfund Consumer Issues/Safety/Products Government Issues Energy/Nuclear Clean Air and Water (quality) Law Enforcement/Crime/Criminal Justice

Estimated quarterly lobbying spending

U.S. Patents

New patents grants

  • Patent Title: Anti-ido antibody and uses thereof Nov. 12, 2024
  • Patent Title: Antibodies against tim3 and uses thereof Oct. 29, 2024
  • Patent Title: Crystalline forms of a par4 inhibitor Oct. 29, 2024
  • Patent Title: Crystal form of 6-(cyclopropanecarboxamido)-4-((2-methoxy-3-(1-methyl-1h-1,2,4-triazol-3-yl)phenyl)amino)-n-(methyl-d Oct. 29, 2024
  • Patent Title: Anti-cd27 antibodies and uses thereof Oct. 08, 2024
  • Patent Title: Triazolopyridinyl compounds as kinase inhibitors Oct. 08, 2024
  • Patent Title: Protein recovery Oct. 01, 2024
  • Patent Title: Serially-connectable drug modules for combinatorial drug delivery device Oct. 01, 2024
  • Patent Title: Automated parallel autosampler system and method for drawing chromatography samples Sep. 24, 2024
  • Patent Title: Treatment of fibrosis, cardiovascular disease and heart failure with modified relaxin polypeptides Sep. 24, 2024
  • Patent Title: Methods of treating kidney failure, and/or improving or stablizing renal function using modified relaxin polypeptides Sep. 24, 2024
  • Patent Title: Assay to determine in vivo receptor occupancy Sep. 10, 2024
  • Patent Title: Imidazothiadiazole and imidazopyrazine derivatives as protease activated receptor 4 (par4) inhibitors for treating platelet aggregation Sep. 10, 2024
  • Patent Title: Indazole carboxamides as kinase inhibitors Sep. 10, 2024
  • Patent Title: Classifying pharmacovigilance documents using image analysis Sep. 03, 2024
  • Patent Title: Methods of treating hla-e-expressing cancers by administering antibodies which bind human natural killer cell inhibitory receptor group 2a (nkg2a) Sep. 03, 2024
  • Patent Title: Phosphorus (v)-based reagents, processes for the preparation thereof, and their use in making stereo-defined organophosphorus (v) compounds Sep. 03, 2024
  • Patent Title: Antibodies and antigen binding peptides for factor xia inhibitors and uses thereof Aug. 20, 2024
  • Patent Title: Biaryl kinase inhibitors Aug. 20, 2024
  • Patent Title: Antibodies to tigit Aug. 13, 2024
  • Patent Title: Synthesis of 1,2,5-tri-o-benzoyl-3-dibenzylamino-3-deoxyribose as intermediate for producing 3′-amino-3′-deoxyadenosine and 3′-amino-3′-deoxyguanosine and the protected derivatives thereof Aug. 13, 2024
  • Patent Title: Bicyclic heteroaryl substituted compounds Aug. 13, 2024
  • Patent Title: Spiroheptanyl hydantoins as rock inhibitors Aug. 13, 2024
  • Patent Title: Inhibitors of indoleamine 2,3-dioxygenase and methods of their use Aug. 13, 2024
  • Patent Title: Treatment of lag-3 positive tumors Jul. 30, 2024
  • Patent Title: Biarylmethyl heterocycles Jul. 16, 2024
  • Patent Title: Uracil derivatives as mer-axl inhibitors Jul. 16, 2024
  • Patent Title: Compositions and methods for producing a composition Jul. 09, 2024
  • Patent Title: Substituted indole ether compounds Jul. 09, 2024
  • Patent Title: Substituted amide compounds useful as farnesoid x receptor modulators Jul. 09, 2024
  • Patent Title: System for determining accuracy of serially-connected drug modules in a combinatorial drug delivery device using voltage Jul. 02, 2024
  • Patent Title: Non-chromatographic purification of macrocyclic peptides by a resin catch and release Jun. 25, 2024
  • Patent Title: Methods of treating prostate cancer Jun. 25, 2024
  • Patent Title: Compositions monovalent for cd28 binding and methods of use Jun. 18, 2024
  • Patent Title: Agonists of ror gammat Jun. 18, 2024
  • Patent Title: Substituted indole dimer compounds Jun. 04, 2024
  • Patent Title: Nucleic acid molecules encoding antibodies which bind natural killer cell inhibitory receptor group 2a protein (nkg2a) May. 14, 2024
  • Patent Title: Substituted thienopyrroles as pad4 inhibitors May. 14, 2024
  • Patent Title: Tetrahydropyran-based thiodisaccharide mimics as galectin-3 inhibitors Apr. 30, 2024
  • Patent Title: Use of anti-pd-1 antibody in combination with anti-cd27 antibody in cancer treatment Apr. 23, 2024
  • Patent Title: Substituted bicyclic compounds useful as t cell activators Apr. 23, 2024
  • Patent Title: [1,2,4]triazolo[1,5-a]pyridinyl substituted indole compounds Apr. 23, 2024
  • Patent Title: Immunomodulators Apr. 09, 2024
  • Patent Title: Anti-cd40 antibodies and uses thereof Apr. 09, 2024
  • Patent Title: Bispecific antibodies against cd3epsilon and ror1 Apr. 09, 2024
  • Patent Title: Nucleic acids encoding anti-trem-1 antibodies Apr. 09, 2024
  • Patent Title: Cyclic dinucleotides as anticancer agents Apr. 02, 2024
  • Patent Title: Devices and systems for delivery of combination therapies Apr. 02, 2024
  • Patent Title: [1,2,4]triazolo[1,5-a]pyridinyl substituted indole compounds Apr. 02, 2024
  • Patent Title: [1,2,4]triazolo[1,5-a]pyridinyl substituted indole compounds Mar. 26, 2024
Government Contracts

Estimated quarterly amount awarded from public contracts

WallStreetBets

Number of mentions of BMY in WallStreetBets Daily Discussion

BMY News

Recent insights relating to BMY

CNBC Recommendations

Recent picks made for BMY stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in BMY

BMY Stock Smart Score

The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.

The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?

Sign Up to view BMY Smart Score

Score Breakdown
Bull Case vs Bear Case

See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.

Example:

Bulls Say:

The Bulls Say summary highlights positive aspects of the stock.

Bears Say:

The Bears Say summary points out potential risks and negative aspects of the stock.

Show More
Back To Top